Harvest One buys lab that showed its CBD capsule “compares favourably” to GW Pharma drug

A successful small-scale, phase-two clinical trial, announced by Harvest One on July 24, 2018 showed that a CBD drug developed  by its subsidiary Satipharm reduced seizures by 82%.

The study was conducted by Israel-based Phytotech Therapeutics, which is was recently purchased by Harvest One from Australia-based MMJ.

MMJ is Harvest One’s 30% owner.

The drug developed by Harvest One’s Satipharm is significant, because UK-based GW Pharmaceuticals recently made history with its patented epilepsy drug – the very first cannabis-based drug to get U.S. FDA approval.

Epidiolex is expected to sell for around US$37,000 for a one-year supply.

GW Pharma trades on the NASDAQ around the US$140 mark.

Satipharm’s clinical trails for its epilepsy medication show that it “compares favourably” to GW Pharmaceutical’s Epilpodex.

The 82 per cent reduction in monthly seizures “have the potential to be a life-altering event for these patients and their families,” said principal investigator Prof. Uri Kramer, Director of Pediatric Epilepsy Service at Tel Aviv Sourasky Medical Center.

For more information on epilepsy

 

Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to CannabisFindings.com with appropriate and specific direction to the original content.

2 thoughts on “Harvest One buys lab that showed its CBD capsule “compares favourably” to GW Pharma drug

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s